Community Schedule

You are currently viewing November 2024

1 results showing for: 'moroctocog alfa [recombinant factor viii]'

Moroctocog alfa [Recombinant factor VIII]

[Xpharm]

Inj 250 iu prefilled syringe
- Brand Fully subsidised brand. Xyntha
- Pharmacode2424339
- Subsidy $287.50
- Measure / Qty per 1

Inj 500 iu prefilled syringe
- Brand Fully subsidised brand. Xyntha
- Pharmacode2424347
- Subsidy $575.00
- Measure / Qty per 1

Inj 1,000 iu prefilled syringe
- Brand Fully subsidised brand. Xyntha
- Pharmacode2424355
- Subsidy $1150.00
- Measure / Qty per 1

Inj 2,000 iu prefilled syringe
- Brand Fully subsidised brand. Xyntha
- Pharmacode2424363
- Subsidy $2300.00
- Measure / Qty per 1

Inj 3,000 iu prefilled syringe
- Brand Fully subsidised brand. Xyntha
- Pharmacode2424371
- Subsidy $3450.00
- Measure / Qty per 1

For patients with haemophilia. Rare Clinical Circumstances Brand of short half-life recombinant factor VIII. Access to funded treatment is managed by the Haemophilia Treaters Group in conjunction with the National Haemophilia Management Group, subject to criteria.

Rectangle page icon symoblising a PDF. PDF
A tick icon. Fully subsidised
An oval with the number 29 in it. Unapproved medicine under Section 29
An asterisk symbol. 3 or 6 months should be dispensed at once
Two duplicate pages icon. Click to copy
A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
OP Original pack
Sole Subsidised Supply